Infinity Bio, Inc.
Baltimore, MD
- UEI
- Z1KXS9WN9EK1
- CAGE
- 9LB79
- Primary NAICS
- 541380 Testing Laboratories and Services
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 6200 Seaforth St A, Baltimore, MD 21224, USA
- Website
- infinitybio.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Virsight profiling from african mosquito bloodmeals (ambis # 2248955) | National Institute of Allergy and Infectious Diseases | $11,000 |
About Infinity Bio, Inc.
Infinity Bio, Inc. is a for-profit corporate entity based in Baltimore, Maryland, registered in SAM.gov and active in federal contracting and grant work. The company appears to specialize in biological research and data analysis, with a focus on environmental health and infectious disease studies. Its registered business structure indicates it is a standard corporate entity not classified as tax-exempt, suggesting a professional research and scientific services orientation.
In terms of federal contract awards, Infinity Bio, Inc. has demonstrated expertise in specialized scientific research, most notably through a $11,000 firm-fixed-price purchase order contract from the National Institute of Allergy and Infectious Diseases (NIAID). This specific contract involves "VIRSIGHT PROFILING FROM AFRICAN MOSQUITO BLOODMEALS" under project AMBIS #2248955, with a completion date of February 28, 2025. The contract was not associated with any specific set-aside designation, indicating a competitive award based on technical merit and capability. The contract's focus on mosquito bloodmeal profiling suggests the company has capabilities in vector-borne disease research and precise biological sampling techniques.
Regarding federal grant awards, Infinity Bio, Inc. has exclusively received sub-awards through the University of South Florida, all related to "The Environmental Determinants of Diabetes in the Young" (TEDDY) study. These sub-awards occurred multiple times throughout 2023 and 2024, with grant dates including October 10, 2023, March 21, 2024, March 27, 2024, and June 6, 2024. The consistent involvement in the TEDDY study indicates the company's specialized expertise in environmental health research, particularly in understanding pediatric diabetes from an environmental perspective. By working as a sub-grantee with a major research university, Infinity Bio, Inc. demonstrates its ability to contribute critical scientific analysis to complex, longitudinal health research projects.
Quick answers
What is Infinity Bio, Inc.'s UEI?
Infinity Bio, Inc.'s Unique Entity ID (UEI) in SAM.gov is Z1KXS9WN9EK1.
What is Infinity Bio, Inc.'s CAGE code?
Infinity Bio, Inc.'s CAGE code is 9LB79.
What is Infinity Bio, Inc.'s primary NAICS code?
Infinity Bio, Inc.'s primary NAICS code is 541380 (Testing Laboratories and Services).
Where is Infinity Bio, Inc. located?
Infinity Bio, Inc.'s physical address in SAM.gov is 6200 Seaforth St A, Baltimore, MD 21224, USA.
Is Infinity Bio, Inc. registered in SAM.gov?
Yes. Infinity Bio, Inc.'s SAM.gov registration is active through October 7, 2027.
What is Infinity Bio, Inc.'s most recent federal award?
Infinity Bio, Inc.'s most recent federal contract award is Virsight profiling from african mosquito bloodmeals (ambis # 2248955) (75N93025P00153), from National Institute of Allergy and Infectious Diseases, on December 9, 2024.
On GovTribe
See Infinity Bio, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors